Ajax-Loading

Astellas Pharma Inc. - Net Receivables

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Net-Receivables" stands at 716.36 Billion Japanese Yens as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Astellas Pharma Inc.'s second quarter, the item "Net Receivables" stands at 716.36 Billion JPY. This represents an increase of 7.10 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.48 percent compared to the value the year prior.
The 1 year change in percent is 25.48.
The 3 year change in percent is 90.84.
The 5 year change in percent is 102.55.
The 10 year change in percent is 103.95.

The Serie's long term average value is 376.78 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 90.12 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2011, to it's latest available value, on 09/30/2025, is +175.12%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Net Receivables for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Receivables905,699,262,464.00
LogoJohnson & Johnson - Net Receivables486,508,953,600.00
LogoAbbVie Inc - Net Receivables399,570,305,024.00
LogoRoche Holding AG - Net Receivables317,433,206,677.55
LogoAstraZeneca PLC - Net Receivables280,205,508,085.11